8-K
filed February 10, 2026, 6:59 PM ET
ticker NKTR
CIK 0000906709
other material
confidence high
sentiment neutral
materiality 0.50
Nektar Therapeutics reports $229.1M cash and investments as of Jan 31, 2026
NEKTAR THERAPEUTICS
- Cash and marketable securities totaled approximately $229.1 million as of January 31, 2026.
- Announcement made on February 10, 2026 via a Regulation FD disclosure.
- The amounts are estimates based on information available as of the announcement date.
- Nektar Therapeutics (ticker: NKTR) listed on the Nasdaq Capital Market.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001193125-26-044751
- form_type
- 8-K
- ticker
- NKTR
- cik
- 0000906709
- company_name
- NEKTAR THERAPEUTICS
- filed_at
- 2026-02-10T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:38.001756+00:00
- generated_at
- 2026-05-16T03:46:49.948660+00:00
- sec_items
- ["7.01"]
- event_type
- other_material
- sentiment
- neutral
- materiality_score
- 0.5
- calibrated_materiality_score
- 0.5
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001193125-26-044751
- json_url
- https://secwatch.observer/filing/0001193125-26-044751.json
- markdown_url
- https://secwatch.observer/filing/0001193125-26-044751.md
- text_url
- https://secwatch.observer/filing/0001193125-26-044751.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/906709/000119312526044751/0001193125-26-044751-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/906709/000119312526044751/d40599d8k.htm
- generated_by_model
- deepseek-v4-flash:cloud
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
SMC
Summit Midstream Corporation announces inaugural $35 million stock repurchase program
Summit Midstream Corp
June 1, 2026, 4:31 PM ET
other_material
Items 7.01, 9.01
same SEC item: 7.01
same event type: other_material
similar materiality
Filing page
SEC filing
LTRX
Lantronix prices $30M common stock offering at $7.20/share; net proceeds ~$32.3M
LANTRONIX INC
June 1, 2026, 4:15 PM ET
other_material
Items 1.01, 7.01, 9.01
same SEC item: 7.01
same event type: other_material
similar materiality
Filing page
SEC filing
RMR
RMR highlights $37B AUM, 40%+ EBITDA margins, and $120M liquidity in investor presentation
RMR GROUP INC.
June 1, 2026, 4:11 PM ET
other_material
Items 7.01, 9.01
same SEC item: 7.01
same event type: other_material
similar materiality
Filing page
SEC filing
EDAP
EDAP TMS holds FocalTherics Investor Day; plans to exit ESWL and distribution segments to focus on HIFU
EDAP TMS SA
June 1, 2026, 4:05 PM ET
other_material
Items 7.01, 9.01
same SEC item: 7.01
same event type: other_material
similar materiality
Filing page
SEC filing
MANH
Manhattan Associates to cut ~6% of global headcount; expects $7M-$9M in severance costs in Q2 2026
MANHATTAN ASSOCIATES INC
June 1, 2026, 4:03 PM ET
other_material
Items 2.05, 7.01
same SEC item: 7.01
same event type: other_material
similar materiality
Filing page
SEC filing
ATRO
Astronics announces 20% Class B stock distribution to all shareholders
ASTRONICS CORP
June 1, 2026, 9:05 AM ET
other_material
Items 7.01, 9.01
same SEC item: 7.01
same event type: other_material
similar materiality
Filing page
SEC filing
CABR
Caring Brands expands licensing deal for Photocil and Hair Enzyme Booster to 5-year term, new territories
Caring Brands, Inc.
June 1, 2026, 8:05 AM ET
other_material
Items 7.01, 9.01
same SEC item: 7.01
same event type: other_material
similar materiality
Filing page
SEC filing
INVH
InvH April-May SS occupancy 97.2%, rent growth 2.5%; valuation discount to NAV
Invitation Homes Inc.
June 1, 2026, 6:45 AM ET
other_material
Items 7.01, 9.01
same SEC item: 7.01
same event type: other_material
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.